Sutro raises $85.4M series E

Sutro Biopharma Inc. (South San Francisco, Calif.) raised $85.4 million on July 26 in an untranched series E round led by new investors Samsara BioCapital and Surveyor Capital.

Also participating in the round were existing investors Alta Partners, Amgen Ventures, Celgene Corp. (NASDAQ:CELG), Lilly Ventures, Skyline Ventures and SV Health Investors, as well as new investors Eventide, Nexthera Capital, Vida Ventures, Merck & Co. Inc. (NYSE:MRK) and funds managed by Tekla Capital Management...